Search research articles
Contact Us
Filters
Showing results (61-70 of 111) with videos related to
Page
of 12
Sort By:
Urologic Oncology
|
September 9, 2015
Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy
In Gab Jeong, Daoud Dajani, Mohan Verghese, et al.
Journal of Korean Medical Science
|
February 8, 2020
Involvement of the TNF-α Pathway in TKI Resistance and Suggestion of TNFR1 as a Predictive Biomarker for TKI Responsiveness in Clear Cell Renal Cell Carcinoma
Hee Sang Hwang, Yun Yong Park, Su Jin Shin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 19, 2020
Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma
Sung Sun Kim, Yong Mee Cho, Gi Hwan Kim, et al.
The Journal of Urology
|
June 16, 2009
Age at diagnosis is an independent predictor of small renal cell carcinoma recurrence-free survival
In Gab Jeong, Chang Hee Yoo, Kanghyon Song, et al.
Human Pathology
|
July 16, 2008
Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy
Hyeon Joo Jeong, Su-Kil Park, Yong Mee Cho, et al.
Journal of Korean Medical Science
|
August 5, 2015
Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
So Dug Lim, Yong Mee Cho, Gyu-Seog Choi, et al.
Pathology Oncology Research : POR
|
October 1, 2017
Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma
Heounjeong Go, Mun Jung Kang, Pil-Jong Kim, et al.
Frontiers in Oncology
|
October 14, 2022
Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
Jwa Hoon Kim, Gi Hwan Kim, Yeon-Mi Ryu, et al.
Journal of Cancer Research and Clinical Oncology
|
February 12, 2013
Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component
Inkeun Park, Yong Mee Cho, Jae-Lyun Lee, et al.
Oncotarget
|
July 1, 2015
miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
Nahyun Choi, Jongmin Park, Jeon-Soo Lee, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 111) with videos related to
Sort By:
Page
of 12
Urologic Oncology
|
September 9, 2015
Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy
In Gab Jeong, Daoud Dajani, Mohan Verghese, et al.
Journal of Korean Medical Science
|
February 8, 2020
Involvement of the TNF-α Pathway in TKI Resistance and Suggestion of TNFR1 as a Predictive Biomarker for TKI Responsiveness in Clear Cell Renal Cell Carcinoma
Hee Sang Hwang, Yun Yong Park, Su Jin Shin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 19, 2020
Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma
Sung Sun Kim, Yong Mee Cho, Gi Hwan Kim, et al.
The Journal of Urology
|
June 16, 2009
Age at diagnosis is an independent predictor of small renal cell carcinoma recurrence-free survival
In Gab Jeong, Chang Hee Yoo, Kanghyon Song, et al.
Human Pathology
|
July 16, 2008
Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy
Hyeon Joo Jeong, Su-Kil Park, Yong Mee Cho, et al.
Journal of Korean Medical Science
|
August 5, 2015
Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
So Dug Lim, Yong Mee Cho, Gyu-Seog Choi, et al.
Pathology Oncology Research : POR
|
October 1, 2017
Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma
Heounjeong Go, Mun Jung Kang, Pil-Jong Kim, et al.
Frontiers in Oncology
|
October 14, 2022
Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
Jwa Hoon Kim, Gi Hwan Kim, Yeon-Mi Ryu, et al.
Journal of Cancer Research and Clinical Oncology
|
February 12, 2013
Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component
Inkeun Park, Yong Mee Cho, Jae-Lyun Lee, et al.
Oncotarget
|
July 1, 2015
miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression
Nahyun Choi, Jongmin Park, Jeon-Soo Lee, et al.
Page
of 12